宣泰医药 (688247)
Sinotherapeutics Inc.
K-Line Chart
No K-line data available
Company NameShanghai Xuantai Pharmaceutical Technology Co., Ltd.
Listing Date2022-08-25
Issue Price9.37RMB
Registered Capital4533410k RMB
Legal RepresentativeGuo Mingjie
Registered AddressRoom 709, 7th Floor, No. 780 Cailun Road, China (Shanghai) Pilot Free Trade Zone
IndustryChemical Pharmaceuticals
Main BusinessR&D, production, and sales of high-end generic drugs and CRO services
Company ProfileShanghai Xuantai Pharmaceutical Technology Co., Ltd. is a high-tech enterprise driven by R&D innovation, primarily engaged in the R&D, production, and sales of generic drugs and CRO services.
The company has independently completed 4 ANDA filings and 6 NMPA filings for its self-developed generic drugs; for co-developed generic drugs, it has completed 2 ANDA filings and 3 NMPA filings. Additionally, the company has several improved new drug projects under development, one of which has received clinical trial approval from the NMPA. The company possesses strong continuous R&D capabilities.
The company has obtained 50 domestic patents, including 16 invention patents, 8 software copyrights, and 14 overseas patents. It has established three major technology platforms: the 'Poorly Soluble Drug Solubilization Technology Platform', the 'Sustained and Controlled Release Drug Formulation R&D Platform', and the 'Fixed-Dose Drug Combination Formulation R&D Platform', demonstrating strong scientific research capabilities and technical expertise.
Stock Details
1. Key Indicators
- Total Shares(W): 200000
- Circulating A-Shares(W): 200000
- Earnings Per Share(RMB): 0.58
- Net Assets Per Share(RMB): 4.96
- Operating Revenue(W RMB): 1260000
- Total Profit(W RMB): 50000
- **Net Profit Attributable to Parent(W RMB) **: 45000
- Net Profit Growth Rate(%): -10.5
- Weighted Return on Equity(%): 4.65
- Operating Cash Flow Per Share(RMB): 0.75
- Undistributed Profit Per Share(RMB): 2.34
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- Automotive manufacturing
- Automotive sales
- Automotive parts
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automotive Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dfmc.com.cn/
- Company Profile: Dongfeng Motor Corporation Limited is a core enterprise under Dongfeng Motor Group, focusing on the R&D, production, and sales of commercial vehicles and passenger vehicles.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Dongfeng Motor Group | State-Owned Legal Person | 100000 | 50.0 |
| 2 | China Securities Finance Co., Ltd. | National Team | 20000 | 10.0 |
| 3 | Central Huijin Asset Management Ltd. | National Team | 15000 | 7.5 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Foreign Legal Person | 12000 | 6.0 |
| 5 | China Construction Bank Co., Ltd. - ChinaAMC SSE STAR Market 50 Index ETF | Public Fund | 8000 | 4.0 |
| 6 | ICBC - E Fund ChiNext ETF | Public Fund | 6000 | 3.0 |
| 7 | National Social Security Fund 113 Portfolio | National Team | 5000 | 2.5 |
| 8 | Bank of China Co., Ltd. - Harvest CSI 300 ETF | Public Fund | 4000 | 2.0 |
| 9 | CITIC Securities Co., Ltd. | Broker | 3000 | 1.5 |
| 10 | Guotai Junan Securities Co., Ltd. | Broker | 2000 | 1.0 |
5. Concept Sectors
- New Energy Vehicle
- Fuel Cell
- Huawei Auto
- Vehicle Networking
- Autonomous Driving
Remarks
- Data update date: 2024-12-31
- Data source: Public Market Information